Clinical Trial Update: Enhancing Social Interaction With an AlterEgo Artificial Agent [NA]

View source ↗

Summary

Clinical trial update describing the use of an AlterEgo artificial agent to enhance social interaction in schizophrenia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Schizophrenia | NA | Status: UNKNOWN